Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
62,036,250
-
Total 13F shares
-
39,572,750
-
Share change
-
+1,445,577
-
Total reported value
-
$2,632,379,192
-
Put/Call ratio
-
137%
-
Price per share
-
$66.52
-
Number of holders
-
100
-
Value change
-
+$96,237,781
-
Number of buys
-
56
-
Number of sells
-
36
Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q2 2018
As of 30 Jun 2018,
Ascendis Pharma A/S - American Depositary Shares (ASND) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,572,750 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, Sofinnova Ventures Inc, Vivo Capital, LLC, venBio Select Advisor LLC, EcoR1 Capital, LLC, and FARALLON CAPITAL MANAGEMENT LLC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.